Shellifox

The new Moderna Flu shot is now approved, despite it being on hold for a month with no new data provided. - they call it “superior” to standard flu vax- In total, 2.0% of 20,179 participants who received mRNA-1010 contracted flu, compared with 2.8% of 20,124 standard-dose recipients. Truth is, it’s the SAME and of course no placebo cohort was done since they pretend it’s unethical to do so. I can run a study on C, D3, Zinc and prove it to be superior prophylaxis to both of these shots if anyone is interested in funding it. Secondly, 73% of recipients exhibited AE’s. They like to call it mild, but it was only followed via subjective diary for 14 DAYS! None of the known issues with the modmRNA platform were assayed, and no imaging done. Lastly, this is a gene therapy, and should have been scrutinized accordingly. Instead it was once again, classified as a vaccine not only to enjoy the benefit of immunity, but to escape added regulatory scrutiny. My prediction: 80% of all healthcare dollars are spent in last 2 years of life. This is a way to keep stockholders happy, funnel money back to campaigns and off the elderly before they spend too much money. This will still fall behind strain prevalence and once again drive mutation. My guess- more harm than benefit.